Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance

被引：21
|
作者：
Alame-Emane, A. K. [1 ,2 ]
Xu, P. [3 ,4 ]
Pierre-Audigier, C. [1 ,5 ]
Cadet-Daniel, V. [1 ]
Shen, X. [6 ]
Sraouia, M. [5 ]
Siawaya, J. F. Djoba [2 ]
Takiff, H. [7 ]
Gao, Q. [3 ,4 ]
Gicquel, B. [1 ,8 ]
机构：
[1] Inst Pasteur, Unite Genet Mycobacterienne, F-75015 Paris, France
[2] Natl Lab Publ Hlth, Res & Specialised Diagnost Unit, Libreville, Gabon
[3] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China
[4] Fudan Univ, Shanghai Med Coll, Inst Med Microbiol, Key Lab Med Mol Virol, Shanghai 200433, Peoples R China
[5] Bichat Claude Bernard Hosp, Lab Bacteriol, Paris, France
[6] Shanghai Municipal Ctr Dis Control & Prevent, Dept TB Control, Shanghai, Peoples R China
[7] Inst Venezolano Invest Cient, Ctr Microbiol & Biol Celular, Lab Genet Mol, Caracas, Venezuela
[8] Inst Pasteur Shanghai, Emerging Bacterial Pathogens Lab, Shanghai, Peoples R China
来源：
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE | 2015年 / 19卷 / 06期
关键词：
tuberculosis; drug resistance; pyrazinamide; PNCA GENE; SUSCEPTIBILITY; IDENTIFICATION; DIAGNOSIS;
D O I：
10.5588/ijtld.14.0768
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
BACKGROUND: Multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis (TB) constitute a major public health concern. OBJECTIVE: To determine the timing of pncA mutations that confer pyrazinamide (PZA) resistance in relation to mutations conferring resistance to isoniazid (INH) and rifampicin (RMP). DESIGN: Isolates from two major urban centres Paris (101 strains) and Shanghai (171 strains) were investigated for the association of pncA mutations with resistance to drugs other than PZA. RESULTS: The proportion of pncA mutations found in INH-monoresistant strains was not increased. CONCLUSION: pncA mutations associated with PZA resistance were found almost exclusively in MDR-TB strains, underlining the importance of determining PZA resistance when treating MDR- or XDR-TB.
引用
收藏
页码：679 / 684
页数：6
相关论文
共 50 条
  • [1] Pyrazinamide resistance in rifampicin discordant tuberculosis
    Mvelase, Nomonde Ritta
    Singh, Ravesh
    Swe Swe-Han, Khine
    Mlisana, Koleka Patience
    PLOS ONE, 2022, 17 (09):
  • [2] Pyrazinamide resistance in Mycobacterium tuberculosis develops after resistance to rifampicin and is increasingly common as strains become resistant to additional antibiotics
    Emane, A. K. Alame
    Xu, P.
    Pierre-Audigier, C.
    Cadet-Daniel, V.
    Shen, X.
    Sraouia, M.
    Siawaya, J. F. Djoba
    Takiff, H.
    Gao, Q.
    Gicquel, B.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 24 - 25
  • [3] Rifampicin and isoniazid resistance not promote fluoroquinolone resistance in Mycobacterium smegmatis
    Zhou, Qin
    Pu, Na
    Xu, Ge
    Liu, Hangchi
    Jia, Xudong
    Wang, Xiaomin
    Xu, Peng
    PLOS ONE, 2025, 20 (01):
  • [4] Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis
    Pierre-Audigier, C.
    Surcouf, C.
    Cadet-Daniel, V.
    Namouchi, A.
    Heng, S.
    Murray, A.
    Guillard, B.
    Gicquel, B.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (02) : 221 - 223
  • [5] MYCOBACTERIUM-TUBERCULOSIS RESISTANCE TO RIFAMPICIN
    FERNANDEZGUERRERO, ML
    POSADADUENAS, R
    FERNANDEZLAZCANO, F
    PADILLAMANZUCO, JM
    REVISTA CLINICA ESPANOLA, 1978, 150 (06): : 357 - 359
  • [6] MECHANISMS OF RIFAMPICIN RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
    Mahanta, Sailendra Kumar
    Peddinti, Bhavani
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, : 49 - 53
  • [7] No evidence that pyrazinamide resistance is acquired after fluoroquinolone resistance Reply
    Takiff, Howard
    Alame-Emane, Amel-Kevin
    Pierre-Audigier, Catherine
    Gicquel, Brigitte
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (02) : 282 - 283
  • [8] Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update
    Njire, Moses
    Tan, Yaoju
    Mugweru, Julius
    Wang, Changwei
    Guo, Jintao
    Yew, WingWai
    Tan, Shouyong
    Zhang, Tianyu
    ADVANCES IN MEDICAL SCIENCES, 2016, 61 (01): : 63 - 71
  • [9] Resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones
    Chen, Ling
    Zhang, Hong
    LANCET INFECTIOUS DISEASES, 2017, 17 (01): : 24 - 25
  • [10] Pyrazinamide resistance in Mycobacterium tuberculosis fails to bite?
    den Hertog, Alice L.
    Sengstake, Sarah
    Anthony, Richard M.
    PATHOGENS AND DISEASE, 2015, 73 (06):
12345